Second malignancies after breast cancer: the impact of different treatment modalities
about
Cancer survivors in the United States: a review of the literature and a call to actionAssociation between melanocytic nevi and risk of breast diseases: The French E3N prospective cohort.The relative risk of second primary cancers in Queensland, Australia: a retrospective cohort study.Chemotherapy induced microsatellite instability and loss of heterozygosity in chromosomes 2, 5, 10, and 17 in solid tumor patients.Breast cancer survivorship issues.Is symptom-oriented follow-up still up to date?Can the risk of secondary cancer induction after breast conserving therapy be reduced using intraoperative radiotherapy (IORT) with low-energy x-rays?Characteristics and Survival of Breast Cancer Patients with Multiple Synchronous or Metachronous Primary Cancers.Increased risks of third primary cancers of non-breast origin among women with bilateral breast cancer.Risk of second cancer after initial treatment of breast cancer: An Osaka Cancer Registry Database study.Breast Cancer Survivorship Care: Targeting a Colorectal Cancer Education Intervention.Risk Factors, Preventive Practices, and Health Care Among Breast Cancer Survivors, United States, 2010.The Breast-Thyroid Cancer Link: A Systematic Review and Meta-analysisEndometrial pathology in breast cancer patients: Effect of different treatments on ultrasonographic, hysteroscopic and histological findingsLow-dose-area-constrained helical TomoTherapy-based whole breast radiotherapy and dosimetric comparison with tangential field-in-field IMRT.Second malignancies following conventional or combined ²⁵²Cf neutron brachytherapy with external beam radiotherapy for breast cancerSecondary malignancies across the age spectrum.The importance of biopsy in clinically diagnosed metastatic lesions in patients with breast cancer.Prognostic factors for local recurrence following breast-conserving treatment in young women.Risk of second primary cancer after breast cancer treatment.Triple-negative breast cancer possibly transforming into malignant melanoma due to targeted therapy? A case report and review of literature.Analysis of multiple primary cancer autopsy cases associated with breast cancer: 2002-2010.Radiotherapy did not increase thyroid cancer risk among women with breast cancer: A nationwide population-based cohort study.Calculation of organ doses from breast cancer radiotherapy: a Monte Carlo study.Left-sided breast cancer and risks of secondary lung cancer and ischemic heart disease : Effects of modern radiotherapy techniques.Significance of lung biopsy for the definitive diagnosis of lung nodules in breast cancer patients.Primary hepatocellular carcinoma in a patient with history of treated breast cancer: a case report with challenging diagnosis and treatment
P2860
Q26865247-DD8C3348-088A-4F79-8E77-023765018C4EQ33733935-B5BBCB1C-8FC3-4052-AD43-35A9906AD485Q33826856-B3D8BA4E-C893-4629-AF59-C2689925636CQ34659119-095623BF-5BA2-4F11-830E-566B3B0E1850Q34895561-C63CF936-61EA-46E6-B546-C1822083057FQ35084969-77191B42-F92E-4F95-A325-FB7F4311B721Q35677383-478F6D35-CD7E-4BFE-A9C8-789FD610F7FDQ35971016-C8CDDA8F-B7ED-43F6-BFE9-7E9C8B75A33AQ36117185-7985A539-68DF-4D4F-8735-889C2EFFA916Q36126599-A4BC9178-99D4-4C84-BC99-C90127A8053CQ36143729-ECB9023C-10E1-4076-ACD9-A44649C7C4D6Q36490419-5D64831D-91B2-4402-A0EB-F8CAB8F302F7Q36628995-484AE4DC-9EB3-4796-BCAA-E84CB961FAA2Q36774331-3B13770D-26F8-499B-AD58-0DE0DE1CDCF6Q37137579-F81743A9-7B59-43A5-9FAE-D6B06AD16198Q37154048-70E99529-2C49-401E-913B-999B034636ECQ37379773-9ADAF6D1-61C0-4D2D-A41F-03CB6955A685Q37702383-575CFC5A-AAD0-466B-981E-94234E89E03CQ37782089-681ED12B-85EC-4F6D-829C-88227A74D30AQ38129094-305CEAA0-7CA2-460F-A819-0F2AF9CC23CFQ38162093-7633F98A-D836-48C2-8B5F-C88EC7EAB688Q39165451-CA4CF9F6-0A18-42AE-9050-4C10302C2BF0Q40775708-CF0521B5-CC0E-4E67-996C-394DE10DF356Q43472479-E1EB73F4-93F6-439B-BC19-473F0156509DQ47320592-ED5FDDFA-3326-4618-A7B1-8326D5027327Q50052578-09044AC5-B653-4CFC-BFD5-FAEABC7DE7F0Q57815912-C9475142-DB36-4C8A-AF77-1F192C8B6B31
P2860
Second malignancies after breast cancer: the impact of different treatment modalities
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Second malignancies after breast cancer: the impact of different treatment modalities
@ast
Second malignancies after breast cancer: the impact of different treatment modalities
@en
type
label
Second malignancies after breast cancer: the impact of different treatment modalities
@ast
Second malignancies after breast cancer: the impact of different treatment modalities
@en
prefLabel
Second malignancies after breast cancer: the impact of different treatment modalities
@ast
Second malignancies after breast cancer: the impact of different treatment modalities
@en
P2093
P2860
P356
P1476
Second malignancies after breast cancer: the impact of different treatment modalities
@en
P2093
A Fourquet
B Asselain
Institut Curie Breast Cancer Study Group
J-Y Pierga
L Gambotti
Y De Rycke
Y M Kirova
P2860
P2888
P304
P356
10.1038/SJ.BJC.6604241
P407
P577
2008-02-12T00:00:00Z